The Journal of Experimental Medicine
ELISpot, FluoroSpot and ELISA kits from Mabtech
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 180K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kishi, S.
Right arrow Articles by Yonehara, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kishi, S.
Right arrow Articles by Yonehara, S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1997/7/57/ $5.00
The Journal of Experimental Medicine, Volume 186, Number 1, July 7, 1997 57-64

Articles

Resistance to Fas-mediated Apoptosis of Peripheral T Cells in Human T Lymphocyte Virus Type I (HTLV-I) Transgenic Mice with Autoimmune Arthropathy

Shuji Kishi*, Shinobu Saijyo{ddagger}, Masaaki Arai§, Shigeru Karasawa||, Susumu Ueda||, Mari Kannagi§, Yoichiro Iwakura{ddagger}, Masahiro Fujii§, and Shin Yonehara

From the * Pharmaceutical Basic Research Laboratories JT Inc., Yokohama 236; {ddagger} Laboratory Animal Research Center, Institute of Medical Science, University of Tokyo, Tokyo 163; § Department of Immunotherapeutics, Medical Research Division, Tokyo Medical and Dental University, Tokyo 113; || Nippon Institute for Biological Science, Tokyo 198; Institute for Virus Research, Kyoto University, Kyoto 606, Japan

Transgenic mice carrying the env-pX region of human T lymphocyte virus type I (HTLV-I) develop autoimmune arthropathy in high incidence. Adopting the approach that Fas-mediated apoptosis has a critical function in the elimination of self-reactive T cells, we examined the involvement of this apoptosis in the induction of autoimmunity in HTLV-I transgenic mice. Splenic T cells derived from the transgenic mice were more resistant to apoptosis induced by anti-Fas mAb than those of the nontransgenic mice, whereas no appreciable difference in apoptosis was detected for thymocytes from either mouse's type. The resistance of transgenic T cells may be due to Tax coded in the pX region, since Tax mediates the inhibition of anti-Fas– induced apoptosis in mature T cell line, Jurkat. Among the transgenic mice, the extent of the resistance to Fas-mediated apoptosis was further enhanced in transgenic T cells with disease. These results suggest that the escape of self-reactive T cells from Fas-mediated apoptosis in the periphery, is critical for the development of autoimmune arthropathy in HTLV-I transgenic mice.

Address correspondence to Shuji Kishi, Pharmaceutical Basic Research Laboratories JT Inc., 1-13-2 Fukuura, Kanazawa-ku, Yokohama 236, Japan. Phone: 81-45-786-7693; FAX: 81-45-786-7692.

1 Abbreviations used in this paper: AICD, activation-induced cell death; HAM/TSP, HTLV-I–associated myelopathy/tropical spastic paraparesis; HAAP, HTLV-I–associated arthropathy; SEB, staphylococcal enterotoxin.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS